High-Impact Cancer Research Program is organized by Harvard Medical School (HMS). This Onsite medical conference will be held from Nov 04, 2019 - Oct 31, 2020, at Harvard Medical School, Boston, Massachusetts, United States of America.
Who Should Apply:
This Harvard Medical School program is open to both new and seasoned researchers including professionals in fundamental and clinical research, population health leaders of cancer-focused enterprises including scientific, policy, and financial top-flight trainees. Prospective students should hold a master’s degree in their field of study, a doctoral degree such as Ph.D., or PsyD and/or a professional degree such as an MD, MBBS, DDM, DMD, PharmD, DNP or foreign equivalent degree.
What is the credit statement of the High-Impact Cancer Research Program?
The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to present continuing medical education for physicians.
This activity meets the criteria of the Massachusetts Board of Registration in Medicine for 7.25 credits of Risk Management Study.
The Harvard Medical School designates this live activity for a maximum of 77.75 AMA PRA Category 1 Credits™. Physicians will be able to earn only the credit commensurate with the extent of their participation in the activity.
The Harvard Medical School designates this enduring material for a maximum of 52.50 AMA PRA Category 1 Credits™. Physicians will be granted the credit commensurate with the extent of their participation in the activity.
What is the significance of the High-Impact Cancer Research Program?
With so many new and promising strategies and recent developments, the opportunities to produce and enable high-impact cancer research are unprecedented. Recent advances continue to expand and reshape our views of the essential features of cancer. We are learning important new aspects of how cancers develop, how to find and diagnose cancers earlier, how to design and unleash powerful new anti-cancer therapies, and how to evaluate cancer risk and even prevent tumors from arising. These advances are delivering useful, productive changes that lead to better cancer outcomes.
High-Impact Cancer Research is the acclaimed Harvard Medical School postgraduate certificate program for cancer research. It teaches the principles and skills shaping today’s most important cancer research activities. High-Impact Cancer Research faculty are distinguished leading experts who have achieved breakthroughs in fields from discovery biology to therapeutics and prevention. In this special program, world leaders in cancer research share their insights and teach this changing science. Participants learn the new fundamentals of a wide spectrum of cancer science and the skills necessary to envision, design, and lead cutting-edge cancer research projects that can contribute to these changes.
What are the objectives of the High-Impact Cancer Research Program?
This program is intended to help participants make high-impact contributions that manage to better cancer outcomes. Upon completion of the program, participants will be able to:
• Explain the molecular and cellular basis of cancer development, detection, diagnosis, treatment, and prevention
• Read about important advances within the context of clinical presentation of various human tumors and ways it is currently being used to develop the growing set of therapeutic and preventive approaches to fighting cancer
• Discover about distinct cancer treatments from the individuals who developed the therapies and are testing them in ongoing clinical trials
• Hone skills necessary to identify and answer key questions needed to make future contributions and to effectively communicate your ideas and conclusions
• Earn critical skills to interpret and assess emerging cancer research
• Envision and design cancer research projects
• Improve writing skills for personal career advancement (e.g., grant applications or funding requests; the science section of a business plan designed to highlight a particular commercial opportunity; papers suitable for submission and publication)
• Form an international network of colleagues and work effectively with international peers
This program allows participants to learn directly from Harvard’s leading faculty in discovery biology and clinical tumor development, and from internationally recognized leaders in the cancer research community who have achieved breakthroughs in therapeutics, risk assessment, and prevention.
Peer-to-peer learning projects allow participants to learn from one another while producing publication-quality reports on important aspects of cancer research. This also allows each participant to develop a large network of international colleagues who will be resources throughout their career.
Students can also customize their learning experience and skills development around their interests and career goals through two optional elective tracks (Communications or Leadership and Management) and an education track for deeper immersion into one of four areas:
• Cancer -Omics
• Clinically challenging cancers
• Risk and prevention
• Therapeutic development
• Three workshops hosted at Harvard Medical School (Boston, MA):
• Workshop 1: November 4 – 8, 2019 (Boston)
• Workshop 2: April 14 – 18, 2020 (Boston)
• Workshop 3: October 26 – 31, 2020 (Boston).
|Registration Type||End Date||Price|
|Early Fee||11 Sep,2019||USD 11,900.00|
|Regular Fee||09 Oct,2019||USD 12,900.00|
Plan Your Travel
Reviews Given by People
Hotels Near Venue
Subscribe to our Newsletterx
Subscribe to our newsletter and receive updates on medical conferences, board review courses and news